Catalyst Wire Dossier Catalyst Wire Dossier

TREDAPTIVE

niacin/laropiprant · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for TREDAPTIVE, covering 2012-12-21 to 2020-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers [Phase 4]

See pricing